Sponsor:
Brooke Army Medical Center
Code:
NCT06699901
Conditions
Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Massive Transfusion Group
Control Group
Brief summary:
Conditions
Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents
Study ID
NCT06699901
Start date
Sep 30, 2024
Status verified date
Feb, 2025
Completion date
Sep 30, 2027
Anticipated
Primary completion date
Jul 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
417 participants
Anticipated
Arms
Control Group
Massive Transfusion Group
Interventions
Massive Transfusion Group
Control Group
Primary outcome measure
Central contacts
Jessica Mendez, MS
jessica.mendez32.ctr@health.milLocations
University of Colorado Hospital
Recruiting
Aurora, Colorado, United States, 80045
Contacts
Principal Investigator:
Adit A Ginde, M.D., M.P.H
Sponsor
Brooke Army Medical Center
Last update posted
Feb 11, 2025
Last verified
Feb, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Brooke Army Medical Center on 2025-02-11.